Paper I — 2025 March (Supplementary) (2010 Scheme) — Q13
2 min read
Paper I
2025 March (Supplementary) (2010 Scheme) · 40 marks · 120 min
Question
Clozapine.
Q131 marksShort Answers
Answer
Uses: Treatment-resistant schizophrenia (failed at least two other antipsychotics); Reduction of suicidal behaviour in schizophrenia
Adverse effects: Agranulocytosis (requires mandatory regular blood count monitoring); Weight gain and metabolic disturbance (most pronounced among the atypicals)